Medication Guide App

CREON 1224 (Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease)

Generic Name: pancrelipase

Pill imprint CREON 1224 has been identified as Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease.

Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for CREON 1224

Creon 120,000 units amylase / 24,000 units lipase /  76,000 units protease CREON 1224
Creon
Generic Name:
pancrelipase
Imprint:
CREON 1224
Strength:
120,000 units amylase / 24,000 units lipase / 76,000 units protease
Color:
Orange / Clear
Size:
11.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Solvay Pharmaceuticals Inc.
National Drug Code (NDC):
00032-1224
Inactive Ingredients:
cetyl alcohol
dimethicone
triethyl citrate
hypromelloses
polyethylene glycol

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)